Bone delivery system having a therapeutic agent
US-2015343114-A1 · Dec 3, 2015 · US
US9717751B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9717751-B2 |
| Application number | US-201314648919-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 10, 2013 |
| Priority date | Dec 14, 2012 |
| Publication date | Aug 1, 2017 |
| Grant date | Aug 1, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The subject matter of the present invention is the use of chitin or a derivative of chitin for preventing and/or treating parasitoses, and in particular cryptosporidiosis. The present invention also pertains to a composition that comprises at least one base agent chosen from among chitin or a derivative of chitin and at least one secondary agent chosen from among an agent for stimulating immunity and an antiparasite agent, as well as the use of same for preventing and/or treating parasitoses, in particular cryptosporidiosis.
Opening claim text (preview).
The invention claimed is: 1. A method for treating cryptosporidiosis comprising administering to humans or animals infected with Cryptosporidium a composition comprising a base agent and an agent for stimulating immunity, wherein the base agent is chosen from chitin or a chitin derivative comprising chitosan, N-acetylglucosamine or glucosamine, and the agent for stimulating immunity is chosen from a yeast cell wall, a yeast extract, selenium, a bacterium of the Bacillus, Lactobacillus, Bifidobacterium, Enterococcus, Propionibacterium, Pediococcus or Lactococcus genus, a yeast of the Saccharomyces or Kluyveromyces genus, or a combination thereof. 2. The method as claimed in claim 1 , wherein the composition also comprises an antiparasitic agent chosen from an essential oil, active carbon, lauric acid, or combinations thereof. 3. The method as claimed in claim 2 , wherein the essential oil is chosen from garlic essential oil, citronella essential oil, cinnamon essential oil, thyme essential oil, oregano essential oil, tea tree essential oil, lemon essential oil, eucalyptus essential oil, or combinations thereof. 4. The method as claimed in claim 1 , wherein the selenium is in the form of a selenium-enriched yeast, selenium totally or partially extracted from yeast, or combinations thereof. 5. The method as claimed in claim 1 , wherein the composition is a food composition, a food supplement or a pharmaceutical composition.
Antiparasitic agents · CPC title
Sulfur, selenium or tellurium; Compounds thereof · CPC title
Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender · CPC title
Lactobacilli, e.g. L. acidophilus or L. brevis · CPC title
Chitin, chitosan · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.